EuroPCR 2023: Late-Breaking Science Video Collection
Published: 18 May 2023
-
Views:
1844
-
Likes:
7
-
Views:
1844
-
Likes:
7
-
Up Next -
30m 41sPart 2 | Session 2 View from the Thoraxcenter: What's Hot at EuroPCR 23?
-
1m 5sPart 4 | Session 1 Dr Lim: Patient Care and Finding Your Passion -
1m 51s -
1m 45sPart 4 | Session 3 Dr Sorajja: Why He Chose Cardiovascular Medicine
-
5m 41sPart 1 | Session 1 EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions Sandeep Arunothayaraj
-
6m 12sPart 1 | Session 2 BASILICA Vs Chimney-Stenting for TAVR-Related Coronary Obstruction Antonio Mangieri
-
3m 15sPart 1 | Session 3 DRAGONFLY-DMR: Safety and Effectiveness of Dragonfly TMVR System for Mitral Regurgitation D Scott Lim
-
3m 30sPart 1 | Session 4 TRILUMINATE Pivotal: TEER for Tricuspid Regurgitation Paul Sorajja
-
6m 7sPart 1 | Session 5 EBC MAIN Three-Year Follow Up David Hildick-Smith
-
4m 59sPart 1 | Session 6 TVT Registry Analysis: TAVR in Patients with Cardiogenic Shock Abhijeet Dhoble
-
2m 35sPart 1 | Session 7 FAME III Three-Year Follow-Up Frederik Zimmermann
Overview
Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research.
Hear commentary on the practice-changing trials of EuroPCR 2023 from selected faculty in our Highlights Reviews.
Watch our Behind the Heart Series to hear more from the personal perspectives of the investigators behind the top trials of EuroPCR 2023.
More from this programme
Part 1
Expert Interviews
Short, concise overviews of the key data revealed at EuroPCR 2023, focussing on the results and impact on future research.
Part 2
View from the Thoraxcenter
In these concise episodes of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their thoughts on the top late-breaking trials that will be presented at EuroPCR 2023.
Part 3
Highlights Reviews
Commentary on the top late-breaking trials of EuroPCR 2023, as chosen by selected faculty.
Part 4
Behind the Heart
Watch our Behind the Heart series to learn more the personal perspectives from the investigators behind top trials in cardiovascular science.
About the episode
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science.
Studies include:
Structural Heart Interventions
00:53: Chimney stenting vs BASILICA to prevent TAVR-related coronary obstruction
2:18: Outcomes of repeat TAVR with balloon-expandable valves
4:18: FAST-TAVI II: Evaluation of Length of Stay After TF-TAVI
Coronary Interventions
6:55: REFORM: Randomised trial of biolimus DEB for in-stent restenosis
8:20: TRANSFORM I: Sirolimus-coated balloon vs. paclitaxel-coated balloon in de novo small vessel disease
Tricuspid
10:43: MITRAL: Outcomes of TMVR vs medical therapy for secondary mitral regurgitation
12:09: DRAGONFLY-DMR: Transcatheter repair by DragonFly device in mitral regurgitation
13:53: CHOICE-MI: Choice of optImal transcatheter treatment for mitral insufficiency registry
Long-term data from PCI trials
16:27: ABSORB IV: Blinded outcomes and angina assessment of coronary bioresorbable scaffolds
18:39: FAME 3: FFR-guided PCI vs CABG - Three-year follow-up
20:06: DEFINE-FLAIR: Functional lesion assessment of intermediate stenosis to guide revascularization
Cardiogenic shock:
20:50: EUROSHOCK: Extracorporeal membrane oxygenation vs standard care in cardiogenic shock
Bifurcation data
23:15: EBC TWO: Provisional vs. culotte for coronary bifurcations
23:52: EBC MAIN: The European Bifurcation Club left main coronary stent study
Renal denervation
26:10: SMART: Pivotal trial of targeted renal denervation to treat hypertension
Faculty Biographies
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center. He is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Comments